M. Wainwright Fishburn, Jr.

Wainwright Fishburn is a prominent venture capital lawyer and Global Chair of Cooley’s Digital Health group.

As a recognized thought-leader, Wain is a frequent speaker at programs addressing industry issues, including at the International CES Digital Health Summit, CNS Summit, Impact Forum, the Samsung: Health + Tech Conference and the Body Computing Conference. Wain chairs the Digital Health Track at the BIO International Annual Meeting.

As both a founder and counsel, Wain has worked with venture-backed companies across a variety of fields. In the digital health sector, clients span across SaMD/regulated devices, remote care and delivery, genomics, biopharma, consumer health and tech-enabled services. Wain also serves as Chairman of the Critical Path Institute, a public-private partnership created in part by the FDA, dedicated to integrating advances in the development pathway with a focus on advancing digital tools.

Wain is past Chairman of the NCI designated Sanford Burnham Prebys Medical Discovery Institute. He is a member of the Executive Committee of the UCSD Moores Cancer Center where he is afforded a clinical perspective on breakthroughs in precision medicine.
Wain is a co-founder of seven companies, two of which went public. Wain is an avid cyclist and while far from an elite athlete, recently cycled 625 miles around the Cape of South Africa and Tour de France routes.